documents: FDA-1996-N-0274-0017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1996-N-0274-0017 | FDA | FDA-1996-N-0274 | Reference 1: Eastern Research Group: "Cost Impact on the Pharmaceutical Industry of Final Sterility Requirements for Inhalation Solution Products" Final Report July 23, 1998 | Supporting & Related Material | Background Material | 2017-01-13T05:00:00Z | 2017 | 1 | 2017-01-13T15:39:25Z | 0 | 0 | 090000648050450c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref